AF
KYNB

Advisornet Financial’s Kyntra Bio KYNB Stock Holding History

Advisornet Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32
Closed -$714 – 2217
2024
Q2 		$714 Sell
32
-48
-60% -$1.48K ﹤0.01% 1878
2024
Q1 		$4.7K Buy
+80
New +$3.45K ﹤0.01% 1450
2020
Q3 		– Sell
-245
Closed -$249K – 1769
2020
Q2 		$249K Hold
245
– – 0.02% 459
2020
Q1 		$213K Hold
245
– – 0.02% 450
2019
Q4 		$263K Hold
245
– – 0.02% 447
2019
Q3 		$227K Hold
245
– – 0.02% 475
2019
Q2 		$277K Sell
245
-8
-3% -$8.76K 0.03% 396
2019
Q1 		$344K Hold
253
– – 0.04% 345
2018
Q4 		$293K Hold
253
– – 0.04% 340
2018
Q3 		$385K Hold
253
– – 0.05% 304
2018
Q2 		$396K Hold
253
– – 0.05% 273
2018
Q1 		$293K Buy
253
+8
+3% +$10.5K 0.04% 324
2017
Q4 		$291K Buy
+245
New +$307K 0.04% 286

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Advisornet Financial's KYNB Position: Q3 2024 in Review

Advisornet Financial sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 32 shares — an estimated $714 sold.

Advisornet Financial first reported a position in KYNB in Q4 2017 and held it in 13 quarters. The position peaked at $396K in Q2 2018. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Advisornet Financial reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Advisornet Financial sold 32 Kyntra Bio shares in Q3 2024, an estimated $714.
  • Advisornet Financial first reported a position in Kyntra Bio in Q4 2017 and held it in 13 quarters.
  • Advisornet Financial's Kyntra Bio position peaked at $396K in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Advisornet Financial's 13F filing for Q3 2024, filed 15 Oct 2024.